BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16432079)

  • 1. Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.
    Novak AJ; Grote DM; Ziesmer SC; Kline MP; Manske MK; Slager S; Witzig TE; Shanafelt T; Call TG; Kay NE; Jelinek DF; Cerhan JR; Gross JA; Harder B; Dillon SR; Ansell SM
    J Clin Oncol; 2006 Feb; 24(6):983-7. PubMed ID: 16432079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
    Cheema GS; Roschke V; Hilbert DM; Stohl W
    Arthritis Rheum; 2001 Jun; 44(6):1313-9. PubMed ID: 11407690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.
    Stohl W; Metyas S; Tan SM; Cheema GS; Oamar B; Xu D; Roschke V; Wu Y; Baker KP; Hilbert DM
    Arthritis Rheum; 2003 Dec; 48(12):3475-86. PubMed ID: 14673998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis.
    Tan SM; Xu D; Roschke V; Perry JW; Arkfeld DG; Ehresmann GR; Migone TS; Hilbert DM; Stohl W
    Arthritis Rheum; 2003 Apr; 48(4):982-92. PubMed ID: 12687540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.
    Cambridge G; Stohl W; Leandro MJ; Migone TS; Hilbert DM; Edwards JC
    Arthritis Rheum; 2006 Mar; 54(3):723-32. PubMed ID: 16508933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia.
    Molica S; Digiesi G; Mauro F; Mirabelli R; Cutrona G; Vitelli G; Morabito F; Iuliano F; Foà R; Ferrarini M
    Leuk Res; 2009 Jan; 33(1):162-5. PubMed ID: 18556064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
    Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
    Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity of monoclonal antibodies OK-CLL (anti-CD5) with peripheral blood cells of patients with B cell lymphoproliferative disorders.
    Milosević D; Marinković M; Jelić S; Colović M; Spuzić I
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):23-9. PubMed ID: 8744680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).
    Sène D; Limal N; Ghillani-Dalbin P; Saadoun D; Piette JC; Cacoub P
    Rheumatology (Oxford); 2007 Jan; 46(1):65-9. PubMed ID: 16782735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients.
    Hong SD; Reiff A; Yang HT; Migone TS; Ward CD; Marzan K; Shaham B; Phei WC; Garza J; Bernstein B; Stohl W
    Arthritis Rheum; 2009 Nov; 60(11):3400-9. PubMed ID: 19877053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma.
    Tecchio C; Nadali G; Scapini P; Bonetto C; Visco C; Tamassia N; Vassilakopoulos TP; Pangalis GA; Calzetti F; Nardelli B; Roschke V; Gottardi M; Zampieri F; Gherlinzoni F; Facchetti F; Pizzolo G; Cassatella MA
    Br J Haematol; 2007 Jun; 137(6):553-9. PubMed ID: 17539776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
    Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia.
    Bogunia-Kubik K; Mazur G; Urbanowicz I; Wróbel T; Kuliczkowski K; Woźniak M; Lange A
    Int J Immunogenet; 2006 Feb; 33(1):21-4. PubMed ID: 16426238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection.
    Fabris M; Quartuccio L; Sacco S; De Marchi G; Pozzato G; Mazzaro C; Ferraccioli G; Migone TS; De Vita S
    Rheumatology (Oxford); 2007 Jan; 46(1):37-43. PubMed ID: 16735452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of expression levels of BLyS and its receptors with multiple myeloma.
    Ju S; Wang Y; Ni H; Wang X; Jiang P; Kong X; Zhong R
    Clin Biochem; 2009 Mar; 42(4-5):387-99. PubMed ID: 19028483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor alpha antagonists: differential effects between good and poor clinical responders.
    La DT; Collins CE; Yang HT; Migone TS; Stohl W
    Ann Rheum Dis; 2008 Aug; 67(8):1132-8. PubMed ID: 17967830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
    Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
    Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
    Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
    Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
    Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W
    Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.